2.47
전일 마감가:
$2.45
열려 있는:
$2.49
하루 거래량:
36,032
Relative Volume:
0.06
시가총액:
$6.64M
수익:
$32.96M
순이익/손실:
$-4.23M
주가수익비율:
-0.0159
EPS:
-155.3294
순현금흐름:
$-14.00M
1주 성능:
-7.49%
1개월 성능:
-15.70%
6개월 성능:
-14.24%
1년 성능:
-99.35%
Sunshine Biopharma Inc Stock (SBFM) Company Profile
명칭
Sunshine Biopharma Inc
전화
954-515-0810
주소
333 LAS OLAS WAY, FORT LAUDERDALE
SBFM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SBFM
Sunshine Biopharma Inc
|
2.4504 | 6.64M | 32.96M | -4.23M | -14.00M | -155.33 |
![]()
ZTS
Zoetis Inc
|
172.87 | 78.07B | 9.15B | 2.43B | 2.31B | 5.32 |
![]()
HLN
Haleon Plc Adr
|
9.865 | 44.59B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.26 | 42.09B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.32 | 18.52B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
127.81 | 13.58B | 612.78M | -86.37M | -62.91M | -0.87 |
Sunshine Biopharma Inc 주식(SBFM)의 최신 뉴스
Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World
Sunshine Biopharma Announces Reverse Stock Split - ACCESS Newswire
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights
Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post
Sunshine Biopharma introduces new generic drugs in Canada - MSN
Sunshine Biopharma Appoints New Chief Commercial Officer - MSN
Sunshine Biopharma Launches Generic Mental Health Drug in Rapidly Growing Canadian Market - StockTitan
Sunshine Biopharma Appoints Michel Roy as Chief Commercial Officer - Defense World
Sunshine Biopharma appoints Michel Roy as CCO - MSN
Sunshine Biopharma names new Chief Commercial Officer By Investing.com - Investing.com South Africa
Sunshine Biopharma names new Chief Commercial Officer - Investing.com
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - WICZ
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 14.6% in December - Defense World
Sunshine Biopharma Inc. Elects New Directors and Ratifies Appointment of Independent Registered Public Accounting Firm - Defense World
Sunshine Biopharma re-elects board, ratifies CPA firm By Investing.com - Investing.com Nigeria
Sunshine Biopharma re-elects board, ratifies CPA firm - Investing.com India
Sunshine Biopharma’s PLpro inhibitor shows activity in SARS-CoV-2 - BioWorld Online
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - AccessWire
Sunshine Biopharma's Novel COVID-19 Oral Treatment Shows Breakthrough Antiviral Activity in Preclinical Study - StockTitan
Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire
Sunshine Biopharma Launches Generic Allergy Drug in $1.3B Global Bilastine Market - StockTitan
Mouse model studies provide proof of concept for Sunshine Biopharma’s K1.1 mRNA product for HCC - BioWorld Online
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - AccessWire
Sunshine Biopharma's K1.1 mRNA Shows Breakthrough Results in Liver Cancer Treatment - StockTitan
SBFM (Sunshine Biopharma) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Operating Income : $-4.91 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Change In Working Capital : $-7.80 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Debt-to-Equity : 0.02 (As of Sep. 2024) - GuruFocus.com
Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com
Stock market today: SKK Holdings Limited +81.83%, Palladyne AI Corp. +50.51% among top gainers in early trading - Business Upturn
Sunshine Biopharma launches generic prescription drug - TipRanks
Sunshine Biopharma launches generic liver drug in Canada - Investing.com
Sunshine Biopharma Launches New Generic Drug in $933M Growing Market | SBFM Stock News - StockTitan
Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline - Investing.com Canada
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com
Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz
Sunshine Biopharma Q3 Revenue Surges 42% to $8.4M Despite Widening Losses - StockTitan
SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
First Citizens Bancshares (OTC:FIZN) Stock Price Down 4.3% – Should You Sell? - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma Inc (SBFM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):